Showing results (71-80 of 111) with videos related to
Sort By:
Pageof 12
Arthritis and Rheumatism|May 28, 2010
The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritisAmalia P Raptopoulou, George Bertsias, Dimitrios Makrygiannakis, et al.Cancer Research and Treatment|March 28, 2019
Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon CancerMaria Sfakianaki, Chara Papadaki, Maria Tzardi, et al.Cancers|July 30, 2020
PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal CancerMaria Sfakianaki, Chara Papadaki, Maria Tzardi, et al.World Journal of Hepatology|July 29, 2014
Clinical outcomes of compensated and decompensated cirrhosis: A long term studyDimitrios N Samonakis, Mairi Koulentaki, Constantina Coucoutsi, et al.Current Oncology (Toronto, Ont.)|March 28, 2023
Achieving a Textbook Outcome in Colon Cancer Surgery Is Associated with Improved Long-Term SurvivalDimitrios K Manatakis, Maria Tzardi, John Souglakos, et al.Plos One|December 25, 2013
BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcomeZacharenia Saridaki, Maria Tzardi, Maria Sfakianaki, et al.Scientific Reports|March 15, 2017
Antagonizing effects of membrane-acting androgens on the eicosanoid receptor OXER1 in prostate cancerKonstantina Kalyvianaki, Veronika Gebhart, Nikolaos Peroulis, et al.Toxicology Letters|June 28, 2016
Nephrotoxicity in rabbits after long-term nandrolone decanoate administrationChristina Tsitsimpikou, Fotini Vasilaki, Konstantinos Tsarouhas, et al.Plos One|February 2, 2011
Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patientsZacharenia Saridaki, Maria Tzardi, Chara Papadaki, et al.Arthritis and Rheumatism|January 1, 2009
Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosusGeorge K Bertsias, Magda Nakou, Christianna Choulaki, et al.Pageof 12